Related Experiment Video

Updated: Aug 21, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Chlamydia pneumoniae antibodies and inflammatory reaction in patients with ischemic heart disease

D Zdrenghea1, G Bodizs, C Taloş

  • 1Division of Cardiology, Rehabilitation Hospital, University of Medicine Cluj-Napoca, 46-50, Viilor Str., 3400 Cluj, Napoca.

Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|November 9, 2004
PubMed

Insights

Chlamydia pneumoniae infection shows a link to inflammation in ischemic heart disease patients. This study found a relationship between Chlamydia pneumoniae antibodies and C-reactive protein (CRP), indicating an inflammatory response.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Ischemic heart disease (IHD) is a major global health concern.
  • Emerging evidence suggests infectious agents, like Chlamydia pneumoniae, may play a role in IHD pathogenesis.
  • Inflammatory markers are crucial in understanding cardiovascular disease progression.

Purpose of the Study:

  • To investigate the association between Chlamydia pneumoniae infection markers and key inflammatory indicators (CRP and IL-8) in patients with IHD.
  • To explore potential differences in these markers across various IHD subtypes (acute myocardial infarction, unstable angina, stable effort angina).

Main Methods:

  • Study included 87 IHD patients (29 acute MI, 18 unstable angina, 40 stable angina).
  • Chlamydia pneumoniae IgG and IgA antibodies were measured using indirect ELISA.
  • C-reactive protein (CRP) levels were determined by radial immunodiffusion.
  • Interleukin-8 (IL-8) was quantified using a commercial ELISA kit.

Main Results:

  • Chlamydia pneumoniae IgG antibodies were detected in 29% of patients, with a higher prevalence in unstable angina (50%).
  • IgA antibodies, indicating chronic infection, were present in 56% of patients with IgG antibodies.
  • CRP levels were significantly higher in patients with positive IgG antibodies compared to those without (52% vs. 34%, p < 0.01).
  • IL-8 levels did not show a significant difference between patients with and without IgG antibodies (p > 0.05).

Conclusions:

  • A significant relationship exists between Chlamydia pneumoniae infection and the inflammatory response, as indicated by CRP levels, in patients with ischemic heart disease.
  • The study suggests that neutrophils are not directly implicated in this Chlamydia pneumoniae-associated inflammatory process in IHD.
  • Further research is warranted to elucidate the precise mechanisms linking Chlamydia pneumoniae to cardiovascular inflammation.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...